Given that D-AKAP1 robustly and rapidly undergoes Siah2-mediated degradation during ischemia, it is conceivable that small molecular compounds that can coactivate PKA or stabilize endogenous levels of D-AKAP1 may confer significant protection during ischemia. The gene discussed is SIAH2; the disease is ischemia.